BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
196 results:

  • 1. notch1-Related Leukoencephalopathy: A Novel Variant and Literature Review.
    Della Vecchia S; Tessa A; Pasquariello R; Seabra L; Crow YJ; Battini R
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474113
    [No Abstract]    [Full Text] [Related]  

  • 2. Sirtuin 3 regulates astrocyte activation by reducing notch1 signaling after status epilepticus.
    Zhu J; Park S; Kim SH; Kim CH; Jeong KH; Kim WJ
    Glia; 2024 Jun; 72(6):1136-1149. PubMed ID: 38406970
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma.
    Zhang Q; Wang J; Zhang J; Wang Y; Wang Y; Liu F
    Cell Signal; 2024 Mar; 115():111016. PubMed ID: 38128708
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
    Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
    Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the notch1 pathway.
    Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
    Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells.
    Liu G; Zhang P; Chen S; Chen Z; Qiu Y; Peng P; Huang W; Cheng F; Zhang Y; Li H; Xiao Q; Mao F; Wang B; Jiang X; Wan F; Guo D; Yu X
    Neuro Oncol; 2023 Oct; 25(10):1788-1801. PubMed ID: 37083136
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hypocretin-1 suppresses malignant progression of glioblastoma cells through notch1 signaling pathway.
    Huan R; Yue J; Lan J; Wang J; Cheng Y; Zhang J; Tan Y
    Brain Res Bull; 2023 May; 196():46-58. PubMed ID: 36925051
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.
    Wu F; Yin YY; Fan WH; Zhai Y; Yu MC; Wang D; Pan CQ; Zhao Z; Li GZ; Zhang W
    EBioMedicine; 2023 Jan; 87():104410. PubMed ID: 36525723
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mesenchymal-endothelial nexus in breast cancer spheroids induces vasculogenesis and local invasion in a CAM model.
    Li A; Muenst S; Hoffman J; Starck L; Sarem M; Fischer A; Hutter G; Shastri VP
    Commun Biol; 2022 Nov; 5(1):1303. PubMed ID: 36435836
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Thyroid carcinoma metastases to central nervous system and vertebrae.
    Kleinschmidt-DeMasters B; Marshall C
    Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ADAMTS1 as potential prognostic biomarker promotes malignant invasion of glioma.
    Wang S; Zhang J; Wang K; Zhao Y; Liu D
    Int J Clin Oncol; 2023 Jan; 28(1):52-68. PubMed ID: 36371587
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Atypical induction of HIF-1α expression by pericellular notch1 signaling suffices for the malignancy of glioblastoma multiforme cells.
    Lee J; Kim E; Chong K; Ryu SW; Kim C; Choi K; Kim JH; Choi C
    Cell Mol Life Sci; 2022 Oct; 79(10):537. PubMed ID: 36183290
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-30c plays diagnostic and prognostic roles and mediates epithelial-mesenchymal transition (EMT) and proliferation of gliomas by affecting notch1.
    Li M; Liu W; Li J; Zhang H; Xu J
    Sci Rep; 2022 Sep; 12(1):16404. PubMed ID: 36180477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Engineered Nanoerythrocytes Alleviate Central Nervous System Inflammation by Regulating the Polarization of Inflammatory Microglia.
    Yin N; Zhao Y; Liu C; Yang Y; Wang ZH; Yu W; Zhang K; Zhang Z; Liu J; Zhang Y; Shi J
    Adv Mater; 2022 Jul; 34(27):e2201322. PubMed ID: 35483045
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates notch1-WNT5A signaling with stem cell maintenance and angiogenesis.
    Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
    J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
    Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
    J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Monoallelic
    Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
    Front Immunol; 2022; 13():867443. PubMed ID: 35401501
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
    Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
    Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
    Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
    Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.
    Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA
    J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.